Baker MC, Chung L, Fiorentino DF. A mortality risk score model for clinically amyopathic dermatomyositis-associated interstitial lung disease: will it have the necessary “FLAIR” to improve clinical outcomes? Chest. 2020;158(4):1307–9.
Gonçalves Júnior J, Shinjo SK. Calcinosis in juvenile dermatomyositis-epidemiology, pathogenesis, clinical features, and treatment: a systematic review. Curr Rheumatol Rep. 2024;26(2):53–68.
Gonçalves Júnior J, Santos JIA, Shinjo SK. Is hydroxychloroquine useful for the treatment of cutaneous manifestations of idiopathic inflammatory myopathies? A systematic review. Pharmaceuticals. 2025;18(9):1293.
Article PubMed PubMed Central Google Scholar
McPherson M, Economidou S, Liampas A, Zis P, Parperis K. Management of MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a systematic review. Semin Arthritis Rheum. 2022;53(151959):151959.
Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med. 2019;381(3):291–3.
Miyake Z, Ishii A, Okiyama N, Tamaoka A. Amyopathic dermatomyositis combined with peripheral neuropathy. BMJ Case Rep. 2020;13(11):e237250.
Article PubMed PubMed Central Google Scholar
Lian X, Zou J, Guo Q, Chen S, Lu L, Wang R, et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model. Chest. 2020;158(4):1535–45.
Article PubMed CAS Google Scholar
Wang W, Sun X, Xu Y, Tan W, Liu Y, Zhou J. Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease. Immun Inflamm Dis. 2024;12(6):e1332.
Article PubMed PubMed Central CAS Google Scholar
Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Arch Dermatol. 2010;146(1):26.
Article PubMed PubMed Central Google Scholar
Ji Q, Pan W, Zhang D, Hou Y, Wang Z. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study. Front Immunol. 2023;14:1237209.
Article PubMed PubMed Central CAS Google Scholar
Sun Y, Liu Y, Yan B, Shi G. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients. Rheumatol Int. 2013;33(5):1295–302.
Takada T, Aoki A, Asakawa K, Sakagami T, Moriyama H, Narita I, et al. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody-positive amyopathic dermatomyositis. Respir Med. 2015;109(9):1174–80.
Zou J, Chen J, Yan Q, Guo Q, Bao C. Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease. Clin Rheumatol. 2016;35(1):117–25.
Li T, Guo L, Chen Z, Gu L, Sun F, Tan X, et al. Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. Sci Rep. 2016;6:33226.
Article PubMed PubMed Central CAS Google Scholar
Okabayashi H, Ichiyasu H, Hirooka S, Akaike K, Kojima K, Jodai T, et al. Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias. BMC Pulm Med. 2017;17(1):134.
Article PubMed PubMed Central Google Scholar
Huang W, Ren F, Wang Q, Luo L, Zhou J, Huang D, et al. Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies. Clin Exp Rheumatol. 2019;37(5):803–7.
Tang K, Zhang H, Jin H. Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department. Front Med (Lausanne). 2021;8:783416.
Article PubMed PubMed Central Google Scholar
Hensgens MPM, Delemarre EM, Drylewicz J, Voortman M, Krol RM, Dalm VASH, et al. Clinical features and immune-related protein patterns of anti-MDA5-positive clinically amyopathic dermatomyositis Dutch patients. Rheumatology (Oxford). 2022;61(10):4087–96.
Article PubMed CAS Google Scholar
Hirsch S, Pöhler GH, Seeliger B, Prasse A, Witte T, Thiele T. Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis. Clin Exp Med. 2024;24(1):37.
Article PubMed PubMed Central CAS Google Scholar
Lee C-S, Chen T-L, Tzen C-Y, Lin F-J, Peng M-J, Wu C-L, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21(5):391–6.
Pérez-Pérez LC, Suárez-Amor Ó, Sánchez-Aguilar D, Ginarte M, Pereiro M, Toribio J. Dermatomiositis clínicamente amiopática: presentación de tres casos. Actas Dermosifiliogr. 2005;96(5):295–8.
Miyazaki E, Ando M, Muramatsu T, Fukami T, Matsuno O, Nureki S-I, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol. 2007;26(3):436–9.
Bornstein G, Lidar M, Langevitz P, Grossman C. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review. Clin Rheumatol. 2016;35(8):2125–30.
Intapiboon P, Siripaitoon B. Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease. Respir Med Case Rep. 2020;31(101299):101299.
PubMed PubMed Central Google Scholar
Kaenmuang P, Navasakulpong A. Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease. Respirol Case Rep. 2021;9(1):e00701.
Ye W-Z, Peng S-S, Hu Y-H, Fang M-P, Xiao Y. Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual-positive dermatomyositis accompanied by rapidly lung disease: three case reports. World J Clin Cases. 2023;11(23):5580–8.
Article PubMed PubMed Central Google Scholar
Sugisaki K, Takeda I, Iwadate H, Kanno T, Nishimaki T, Kasukawa R. Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis. Fukushima J Med Sci. 2002;48(2):103–10.
Sakamoto N, Mukae H, Fujii T, Yoshioka S, Kakugawa T, Yamaguchi H, et al. Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis. Intern Med. 2004;43(9):838–42.
Rodríguez-Vázquez M, Romero-Aguilera G, García-Arpa M, Martín-Dávila F, Cortina de la Calle P. Paniculitis asociada a dermatomiositis amiopática. Actas Dermosifiliogr. 2004;95(3):189–92.
Yokoyama T, Sakamoto T, Shida N, Kinoshita M, Kunou Y, Karukaya R, et al. Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes. J Intensive Care Med. 2005;20(3):160–3.
Saoud B, Allali F, Hassouni NH. Amyopathic dermatomyositis. Jt Bone Spine. 2006;73(3):318–20.
Galrão L, Reale J, Lima I, Santiago M. Eficácia da dapsona em dois casos de dermatomiosite amiopática. An Bras Dermatol. 2006;81(2):181–2.
Rey MCW, Dazzi PB, Rockenbach M, Bernardes SC, Furian R, Libis AS, et al. Papular mucinosis: uncommon presentation of amyopathic dermatomyositis. Med Cutan Iber Lat Am. 2007;35(4):189–92.
Kakugawa T, Mukae H, Saito M, Ishii K, Ishimoto H, Sakamoto N, et al. Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intern Med. 2008;47(8):785–90.
Comments (0)